Life Sciences Procurement Challenges & Trends: Imperatives for CPOs in 2023

May 02, 2023

Download Whitepaper

AUTHOR(s)

Custom Research by ISG

Key Points

The life sciences industry has made remarkable progress in personalized medicine through precise diagnostic and prognostic tools that were once limited to consumer electronics. Procurement and sourcing have been crucial components in this transformation. However, life sciences organizations face new supply chain and procurement challenges.

As a recent ISG study of Fortune 3000 life sciences procurement leaders emphasizes, life sciences supply chain challenges are unique. Procurement leaders in this industry (64 percent) are most concerned with ensuring supplier diversity while maintaining reliable and sustainable supply chains. On the other hand, procurement leaders in other industries are more worried about labor cost inflation and rising wages.

To continue advancing personalized medicine and devices, life sciences procurement leaders must supplement their existing agenda with new responsibilities, metrics and accountabilities while adhering to the corporate agenda. Digital procurement leaders are responsible for traditional year-over-year savings. They must also be accountable for other metrics that reflect the financial health, market presence and social-economic stewardship of the company. They require reliable procurement spend data and market intelligence to fulfill their responsibilities effectively.

To keep pace with technological advancements in medicine, procurement leaders must source raw materials such as cell substrates, tissues and fluids used in biotechnology innovations for diagnostics and therapeutics. The practicality and ubiquity of wearable and implantable medical devices have improved the quality of life, enhanced biological performance and honed medical predictability. Patient engagement has become more comprehensive and omni-channel, providing new ways of working alongside new scientific developments.

This custom research by ISG, commissioned by WNS, puts the spotlight on the following aspects:

Life sciences procurement trends and challenges in 2023
Technological and service-based solutions that can help organizations realize value and achieve their objectives

Please submit the form to download the whitepaper.

FAQs

1. How can Chief Procurement Officers (CPOs) build resilient procurement strategies in the life sciences industry?

Life sciences procurement leaders must balance cost optimization with supply continuity, regulatory compliance and innovation. Building resilience requires diversified supplier ecosystems, real-time procurement intelligence, predictive risk monitoring and digital procurement platforms. WNS helps life sciences organizations create agile procurement operating models that strengthen supplier resilience while ensuring uninterrupted support for research, manufacturing and commercialization.

2. Why is AI and procurement analytics becoming essential for modern life sciences procurement?

AI-powered procurement analytics enables organizations to improve spend visibility, predict supplier risks, automate sourcing decisions and optimize category management. These capabilities help procurement teams move beyond transactional purchasing to strategic value creation. WNS combines advanced analytics, AI and procurement domain expertise to help CPOs make faster, data-driven sourcing decisions while improving efficiency and compliance.

3. How can procurement leaders balance supplier diversity, sustainability and operational performance?

Modern procurement strategies must support Environmental, Social and Governance (ESG) goals while maintaining quality, regulatory compliance and supply reliability. Supplier diversity and sustainable sourcing have become strategic priorities that enhance resilience and long-term business value. WNS helps life sciences organizations integrate sustainability, supplier governance and procurement intelligence into a unified procurement transformation strategy.

4. What are the biggest procurement challenges facing life sciences organizations today?

Life sciences organizations face increasing pressure from specialized raw material shortages, evolving regulatory requirements, inflation, supplier disruptions and fragmented procurement data. Legacy procurement processes often limit visibility and slow strategic decision-making. WNS helps procurement leaders modernize sourcing operations through intelligent automation, digital procurement platforms and end-to-end procurement transformation frameworks that improve agility and business resilience.

5. Why should life sciences organizations partner with WNS for procurement transformation?

WNS combines deep life sciences and procurement expertise with AI, advanced analytics, category management and intelligent sourcing capabilities. From supplier risk management and strategic sourcing to spend analytics, procurement operations and digital procurement transformation, WNS helps CPOs create resilient, insight-driven procurement organizations that improve business performance, accelerate innovation and deliver sustainable value.